Consistently, the protein analysis of Mcl-1, Bcl-2, and Bax indicated that treatment of the cells with TM-(–)-18 and TM-(–)-4a caused a dramatic reduction in the Mcl-1 protein in all the primary lung cancer cells (Figure 4d). Here, BAX is linked to lung cancer.